Giving daily oral insulin to high-risk relatives of patients with type 1 diabetes did not delay the onset of the condition in the Type 1 Diabetes TrialNet Oral Insulin Study, although the investigators say that doubts surrounding the dose of insulin used means the case is not yet closed.
People with higher levels of linoleic acid biomarkers have a reduced risk for type 2 diabetes than those with lower levels, whereas its metabolite arachidonic acid is not significantly associated with type 2 diabetes risk, study results suggest.
Editorial Board member Jay Shubrook and his colleague Alegria Cantillep discuss the National Diabetes Prevention Program, how you might find eligible patients, and how you can refer them to the program.
This chapter reviews the lessons learned from the Diabetes Prevention Program and the Action for Health in Diabetes studies regarding the health benefits of increasing physical activity in type 2 diabetes.
Gibbs BB, Jakicic JM. In: Diabetes and Exercise. Edited by Reusch JEB, Regensteiner JG, Stewart KJ, Veves A. Springer International Publishing AG, 2018. pp:175–184.